NCT02678793View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)

PHASE2CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

March 31, 2017

Conditions
Morton's Neuroma
Interventions
DRUG

CNTX-4975

Trial Locations (10)

16602

University Orthopedics Center, Altoona

16801

University Orthopedics Center, State College

21122

Chesapeake Research Group, Pasadena

24501

The Education & Research Foundation, Inc., Lynchburg

63303

Center for Advanced Medicine & Research, City of Saint Peters

72401

NEA Baptist Clinic, Jonesboro

76015

Allcare Foot and Ankle Centre, Arlington

84107

Wasatch Clinical Research, Salt Lake City

85023

Arizona Research Center, Phoenix

92020

TriWest Research Associates, LLC, El Cajon

Sponsors
All Listed Sponsors
lead

Centrexion Therapeutics

INDUSTRY

NCT02678793 - A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma) | Biotech Hunter | Biotech Hunter